Therapixel Completes €15M Series B Financing to Deploy MammoScreen® 2D/3D
will accelerate the commercial deployment of its Artificial Intelligence reading solution for 2D/3D mammography, with a focus on the United States
Read More
Financing
UK Start-up Ceryx Medical Raises £3.8m in Seed Funding for Bionic Pacing Device
The funds will be used to commercialise its cardiology technology and commence the first-in-human clinical study of Ceryx’s cardiac rhythm management device, Cysoni, later this year
Read More
BlueWind Medical Raises $64 Million in Series B Funding for Overactive Bladder Treatment
RENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of overactive bladder (OAB)
Read More
Israeli Startup Imagene AI Secures $21.5 Million for Precision Medicine for Cancer
Imagene’s proprietary deep learning algorithms reduce the time required for biomarkers detection from several weeks to two minutes
Read More
Irish Start-up Versono Medical Raises €6.7m for Intravascular Medical Device
to bring its intravascular device to market
Read More
Irish Start-up SymPhysis Medical Raises €1.9 Million for Palliative Care
the funding to be used for finishing product development and expanding into the US market
Read More
HealthBeats™ Raises US$3 Million Seed Funding to Expand Remote Vitals Monitoring in Australia and Singapore
HealthBeats™ has deployed its Remote Vitals Monitoring solution to 30 hospitals and clinics across Australia
Read More
Dutch MedTech Startup STENTiT Raises €1.8 Million in Seed Round
The funding facilitates further pre-clinical development and batch production of a regenerative stent for peripheral indications.
Read More
Thoma Bravo Completes Strategic Growth Investment in Circle Cardiovascular Imaging
will bring significant operational and financial resources to allow Circle CVI to grow its leadership in the global cardiac imaging industry
Read More
Carlsmed Raises $30M in Series B Funding to Scale Personalized Spine Surgery
The company plans to use the Series B funds to ramp commercialization of aprevo®, Carlsmed’s FDA cleared personalized surgical devices
Read More